Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,792 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses.
Wu X, Moming A, Zhang Y, Wang Z, Zhang T, Fu L, Qian J, Ni J, Hu S, Tang S, Zheng X, Wang H, Shen S, Deng F. Wu X, et al. Among authors: ni j. PLoS Negl Trop Dis. 2024 Jun 7;18(6):e0012216. doi: 10.1371/journal.pntd.0012216. eCollection 2024 Jun. PLoS Negl Trop Dis. 2024. PMID: 38848311
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial.
Sha H, Tong F, Ni J, Sun Y, Zhu Y, Qi L, Li X, Li W, Yang Y, Gu Q, Zhang X, Wang X, Zhu C, Chen D, Liu B, Du J. Sha H, et al. Among authors: ni j. Signal Transduct Target Ther. 2024 Jun 7;9(1):143. doi: 10.1038/s41392-024-01857-6. Signal Transduct Target Ther. 2024. PMID: 38844468 Clinical Trial.
Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy.
Zhang J, Gao J, Jiang S, Mao J, Chu L, Chu X, Yang X, Li Y, Guo T, Zhou Y, Xu D, Hu J, Chu Q, Ni J, Zhu Z. Zhang J, et al. Among authors: ni j. Cancer Immunol Immunother. 2024 Jun 4;73(8):140. doi: 10.1007/s00262-024-03720-7. Cancer Immunol Immunother. 2024. PMID: 38833011 Free PMC article.
4,792 results